4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-22-005823
Options or other derivatives
- CEO acquired 392,312 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-02-14 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +297,037 | $20.00 | 2032-02-13 | 297,037 | 297,037 | D |
| 2022-02-14 | Grant or award : show line 2 in the form Restricted Stock Units | +95,275 | 95,275 | 95,275 | D |
Loading xslF345X03/form4.xml…